Vet-Stem, Inc. Proudly Sponsors the Regenerative Medicine Sessions at the Fourth World Veterinary Orthopaedic Congress |
January 30, 2014 --
Vet-Stem, Inc., the leading Regenerative Veterinary Medicine company is proud to announce their co-sponsorship of the Veterinary Orthopedic Society/North American Veterinary Regenerative Medicine Association Regenerative Medicine sessions at the fourth World Veterinary Orthopaedic Congress. The Congress will be taking place at the Beaver Run Resort in Breckenridge, Colorado from March 1st through the 8th of this year.
Vet-Stem has always supported the Veterinary Orthopedic Society (VOS) and the North American Veterinary Regenerative Medicine Association (NAVRMA) in the promotion of education and new information in the veterinary industry. The VOS/NAVRMA Regenerative Medicine sessions at the Congress will be discussing and presenting topics concerning sources of stem cells as well as use of stem cells and other cellular therapies for ligament, tendon, and cartilage injuries in dogs and horses.
Robert Harman, DVM, Founder and CEO Vet-Stem spoke recently at the NAVRMA Conference in Atlanta, Georgia. His presentation titled “One Medicine and Collaboration for Rapid Development of Cell Therapy” showed a model and examples of collaborations between commercial, academic, human and veterinary groups to the betterment of all medical progress. He illustrated how veterinary stem cell medicines have impacted the clinical progress of human stem cell medicines development.
Dr. Harman pulls from his biotechnology and veterinary experience to help Vet-Stem perfect the clinical application of regenerative therapies for various types of injuries, illnesses, and other healing-promoting applications. Vet-Stem is leading in the development for regenerative medicine in the veterinary field, with over 10,000 animals treated in the last 10 years.
About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.’s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure.
< Back to Press Releases